Viewing Opinion | StockChase
Biogen IDEC Inc. (BIIB-Q) opinion on 2017-03-16

Last Price Recorded: 313.9800 on 2017-11-16

ON STOCKCHASE SINCE May 2004

biotechnology/pharmaceutical
TOP PICK

Gordon Reid
Biogen IDEC Inc. was $278.960 at time of opinion
Owned : Yes

A bio pharmaceutical. If you look at the traditional Pharma space, the chemical-based companies, the bio-based companies were always out there, coming along, but basically not making a lot of money and were often single drug companies, virtually reinvesting all their cash flow. They have now matured and into much stronger growth companies than the traditional pharmas. They also have lower multiples than they did 5-6 years ago. That makes it quite attractive. (Analysts’ price target is $305.)

UNKNOWN

All opinions for BIIB-Q (19)

1 BUY
1 BUY on WEAKNESS
5 COMMENT
2 DON'T BUY
1 HOLD
1 PARTIAL SELL
2 PAST TOP PICK
4 TOP PICK
2 WAIT
View All

More experts covering BIIB-Q

SAVE
Add BIIB-Q to Watch List

All opinions for BIIB-Q (19)

1 BUY
1 BUY on WEAKNESS
5 COMMENT
2 DON'T BUY
1 HOLD
1 PARTIAL SELL
2 PAST TOP PICK
4 TOP PICK
2 WAIT
View All

More experts covering BIIB-Q

SAVE
Add BIIB-Q to Watch List

No Comments.


You must be logged in to comment.

Successfully Saved Company